In an exciting collaboration, modern mental health company, Clerkenwell Health, and Beckley Psytech, a clinical-stage biotechnology company, have launched a phase 2a study aimed at investigating a potential breakthrough treatment for alcohol use disorder (AUD).
NOVEL PSYCHEDELIC COMPOUND TO BE TESTED FOR TREATMENT OF ALCOHOL USE DISORDER Novel psychedelic compound, combined with psychological support, will be explored as a potential new treatment for people living with alcohol use disorder (AUD).The trial uses Beckley Psytech’s lead candidate BPL-003, a short-du.
The Sioux City Ghosts blend of athletic prowess and slapstick earned comparisons to basketball s Harlem Globetrotters. Like the Globetrotters, the Ghosts came into being when Black athletes were kept from